Why NKTX? Nkarta, Inc. Analysis, Price & AI Insights | Whystock
NKTX
$2.93+0.16 (+5.78%)
Market ClosedLast close May 1
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.